Favorable Effects of Tacrolimus Monotherapy on Myasthenia Gravis Patients

Background and Purpose: Tacrolimus (TAC) has been proven to be a rapid-acting, steroid-sparing agent for myasthenia gravis (MG) therapy. However, evidence related to the effectiveness of TAC alone is rare. Therefore, this study was performed to investigate the effect of TAC monotherapy in MG patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Fan, Zhirong, Li, Zunbo, Shen, Faxiu, Zhang, Xueping, Lei, Lin, Su, Shengyao, Lu, Yan, Di, Li, Wang, Min, Xu, Min, Da, Yuwei
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7652845/
https://ncbi.nlm.nih.gov/pubmed/33193063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.594152
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados